Irish PharmaChem 2020

Page 58

Cell Engineering Technology

Avectas:

Engineering cells fit for immunotherapy

Avectas is at the cutting edge of cell engineering technology; its SoluporeÂŽ nonviral technology has the potential to revolutionise cell therapy for patients. 56

Avectas believes that in a cGMP manufacturing setting, SoluporeÂŽ will deliver efficacy, safety and reduced cost of goods, while decreasing the time required to deliver modified cells to patients. Irish PharmaChem | Industry Buyers Guide 2020